![Michelle Doig](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michelle Doig
Gründer bei
OMEGA ALPHA SPAC
Profil
Ms. Michelle Doig is an Independent Director at Bridgebio Oncology Therapeutics, Inc. /New/, a President & Director at Omega Alpha SPAC and a Partner & Head-Corporate Development at Omega Fund Management LLC.
She is on the Board of Directors at Bridgebio Oncology Therapeutics, Inc., Bridgebio Oncology Therapeutics, Inc. /New/, Artios Pharma Ltd., Omega Alpha SPAC and Nuvation Bio Operating Co., Inc. Ms. Doig was previously employed as a Director-Corporate Finance by Third Rock Ventures LLC, a Principal by Abingworth LLP, an Associate by Lehman Brothers, Inc., an Associate by J.P.
Morgan & Co., Inc. (Delaware), an Analyst by Morgan Stanley, and a Manager by Student Works Management Program.
She also served on the board at Nuvation Bio, Inc. She received her undergraduate degree from Richard Ivey School of Business.
Aktive Positionen von Michelle Doig
| Unternehmen | Position | Beginn |
|---|---|---|
| OMEGA ALPHA SPAC | Gründer | 01.11.2020 |
Omega Fund Management LLC
 Omega Fund Management LLC Investment ManagersFinance Omega Fund Management invests in private and public companies located in the US and Europe. The firm focuses on sectors such as biotechnology, life sciences, healthcare and medical devices. It provides financing for seed, early, mid and later stage capital requirements. It makes direct secondary investments along with follow-on investments. | Private Equity Investor | 01.01.2016 |
Nuvation Bio Operating Co., Inc.
 Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Develops novel oncology therapeutic candidates | Direktor/Vorstandsmitglied | - |
Artios Pharma Ltd.
 Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for cancer treatment | Direktor/Vorstandsmitglied | 01.07.2021 |
Ehemalige bekannte Positionen von Michelle Doig
| Unternehmen | Position | Ende |
|---|---|---|
| NUVATION BIO INC. | Direktor/Vorstandsmitglied | 31.07.2021 |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm targets companies operating in the fields of the healthcare sector. It provides financing for early stage capital requirements. It acts as a lead investor. | Private Equity Investor | 31.12.2016 |
Abingworth LLP
 Abingworth LLP Investment ManagersFinance Abingworth invests in both private and public companies located across Europe and the United States. The firm targets companies operating in the fields of life sciences and healthcare sectors. It provide financing for seed, early, later and clinical co-development stage capital requirements with an investment size of USD 15 - 30 million. | Corporate Officer/Principal | 01.11.2013 |
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance Provides investment banking services | Corporate Officer/Principal | 01.01.2002 |
J.P. Morgan & Co., Inc. (Delaware)
 J.P. Morgan & Co., Inc. (Delaware) Financial ConglomeratesFinance Provides financial services | Corporate Officer/Principal | 01.03.2001 |
Ausbildung von Michelle Doig
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
76
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Lehman Brothers, Inc.
Lehman Brothers, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Morgan Stanley
 Morgan Stanley Investment ManagersFinance Provides wealth and asset management, trading & investment banking services | Finance |
Abingworth LLP
Abingworth LLP Investment ManagersFinance Abingworth invests in both private and public companies located across Europe and the United States. The firm targets companies operating in the fields of life sciences and healthcare sectors. It provide financing for seed, early, later and clinical co-development stage capital requirements with an investment size of USD 15 - 30 million. | Finance |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm targets companies operating in the fields of the healthcare sector. It provides financing for early stage capital requirements. It acts as a lead investor. | Finance |
Omega Fund Management LLC
Omega Fund Management LLC Investment ManagersFinance Omega Fund Management invests in private and public companies located in the US and Europe. The firm focuses on sectors such as biotechnology, life sciences, healthcare and medical devices. It provides financing for seed, early, mid and later stage capital requirements. It makes direct secondary investments along with follow-on investments. | Finance |
Richard Ivey School of Business
 Richard Ivey School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for cancer treatment | Health Technology |
J.P. Morgan & Co., Inc. (Delaware)
J.P. Morgan & Co., Inc. (Delaware) Financial ConglomeratesFinance Provides financial services | Finance |
Nuvation Bio Operating Co., Inc.
Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Develops novel oncology therapeutic candidates | Health Technology |
Omega Alpha SPAC
 Omega Alpha SPAC Financial ConglomeratesFinance Operates as a blank check company | Finance |
Nuvation Bio, Inc.
 Nuvation Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops oncology related novel therapeutic candidates | Health Technology |
